Technical Intelligence & Insights
Explore our curated collection of technical analyses and commercial scale-up strategies specifically focused on Hepatitis C Inhibitors. These insights are designed to support R&D and procurement teams in optimizing their supply chains.
Patent CN114989067B reveals a high-yield synthetic route for Paritaprevir intermediates, offering cost reduction and scalable manufacturing for global supply chains.
Novel safe synthesis of N-methyl-5-hexene-1-amine eliminating explosive hydrogen risks. High purity >95%, green process for pharma intermediates.
Discover a scalable, air-tolerant 3-cyanindole synthesis method with 88% yield. Reduce costs and supply chain risks for cardiovascular drug intermediates.